We only have this paper's title and publication details.
Read it at the sourceClinical analysis demonstrates CAR T cells persist and induce sustained remissions in chronic lymphocytic leukemia, indicating durable therapeutic efficacy.
CAR T cells persist and sustain remissions in advanced chronic lymphocytic leukemia.
No takes yet. Share an insight, caveat, or question.
Porter et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: